Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under the Age of 24 Months
Dravet syndrome is a genetic epilepsy associated with pathogenic variants in SCN1A that codes for Nav1.1, a protein necessary for sodium channels. Children wit…
Dravet Syndrome (DS)Children Under 2 Years
Estimated
~$10 – $6,250
University of Colorado, DenverNCT06598449
Phase 1
Preliminary Evaluation of the Safety and Efficacy of CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in Individuals Diagnosed with Dravet Syndrome And/or Lennox-Gastaut Syndrome
This study is a preliminary open-label, single-arm Phase II investigation into the safety and efficacy of transdermal cannabidiol (CBD) delivered using GT4 ski…
Lennox-Gastaut Syndrome (LGS)Dravet Syndrome (DS)
Estimated
~$10 – $7,500
Alexander RotenbergNCT06738732